ProfileGDS4459 / ENSG00000186119
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 12% 6% 13% 19% 10% 8% 5% 12% 7% 9% 3% 11% 11% 3% 10% 7% 7% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.9712
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.716
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.5313
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.4219
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.4710
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.478
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 71.915
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.4712
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.097
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.389
GSM623474group B, liver allograft wedge biopsie placebo treatment 11.993
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.3711
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.4711
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.423
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.2510
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.687
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.757